Regulation of Plasminogen Activator Activity in Human Fibroblastic Cells by Fibrosarcoma Cell-derived Factors

Olli Saksela, Marikki Laiho, Jorma Keski-Oja

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Low-molecular-weight protein factors (Mr 8,000 to 18,000) from serum-free conditioned medium of human fibrosarcoma (8387) cells reversibly enhanced the secretion of proteinase-inhibitory activity by cultured normal human skin fibroblasts. This inhibitory activity could be absorbed by immobilized plasminogen activator (PA) of urokinase type but not by heparin, and it was sensitive to treatment with sodium dodecyl sulfate. The secretion of a heparin-binding Mr 60,000 proteinase inhibitor, resembling protease nexin, was also detected. Early passages of adult skin fibroblasts do not contain or secrete PA. When cell types secreting this enzyme were tested, the fibrosarcoma-derived factors decreased the PA secretion detectable after sodium dodecyl sulfate treatment in all conditioned media of normal and malignant fibroblastic cells examined, including the 8387 cell line itself. However, no effects on the secretion of PA by normal or malignant cells of epithelioid origin or by melanoma cells were seen. A similar preparation from human epidermoid carcinoma (A431)-conditioned medium did not affect the PA activity or secretion of proteinase inhibitors from fibroblastic cells. The ability of sarcoma cells to modulate the production of PA inhibitors is a novel characteristic in the regulation of cellular proteolysis.

Original languageEnglish (US)
Pages (from-to)2314-2319
Number of pages6
JournalCancer Research
Issue number5
StatePublished - May 1 1985
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Regulation of Plasminogen Activator Activity in Human Fibroblastic Cells by Fibrosarcoma Cell-derived Factors'. Together they form a unique fingerprint.

Cite this